Evidence map›Paper›PMID 41013772›Full record

SynthesisStem cell research & therapy2025

Efficacy and safety of single versus repeated injections of mesenchymal stem cells for the treatment of knee osteoarthritis: a systematic review and network meta-analysis of randomized controlled trials.

Li Deng, Chongyu Zhao, Liming Zhou, Xiaoyu Mu, Haomin Sun, Li Li, Ying Zhang

Abstract readSystematic ReviewNetwork Meta-Analysis
In one paragraph

Synthesis in Stem cell research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Li DengDepartment of Orthopedics, Kunming Municipal Hospital of Traditional Chinese Medicine, Kunming, Yunnan, China.
Chongyu ZhaoDepartment of Orthopedics, Kunming Municipal Hospital of Traditional Chinese Medicine, Kunming, Yunnan, China.
Liming ZhouDepartment of General Practice, Kunming Municipal Hospital of Traditional Chinese Medicine, Yunnan, Kunming, China.
Xiaoyu MuDepartment of Orthopedics, Kunming Municipal Hospital of Traditional Chinese Medicine, Kunming, Yunnan, China.
Haomin SunDepartment of Orthopedics, Kunming Municipal Hospital of Traditional Chinese Medicine, Kunming, Yunnan, China.
Li LiDepartment of Orthopedics, Kunming Municipal Hospital of Traditional Chinese Medicine, Kunming, Yunnan, China. 148420420@qq.com.
Ying ZhangDepartment of Orthopedics, The Affiliated Hospital Southwest Medical University, Luzhou, 646000, Sichuan, China. Zying20242024@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn recent years, mesenchymal stem cells (MSCs) have been widely applied in the clinical treatment of knee osteoarthritis (KOA), demonstrating promising therapeutic efficacy. However, intervention protocols for MSCs have not yet been standardized, and evidence regarding the impact of different injection frequencies on the efficacy and safety of MSC treatment in KOA remains limited.

objectiveThis study aims to integrate evidence from conventional and network meta-analyses to evaluate the efficacy and safety of different intervention frequencies (single vs. repeated MSC injections) in the treatment of knee osteoarthritis (KOA).

methodsA systematic search was conducted in PubMed, Embase, the Cochrane Library, and Web of Science databases up to March 1, 2025. Traditional meta-analysis was performed to assess the efficacy and safety of MSC therapy for KOA, followed by a network meta-analysis (NMA) to evaluate the effectiveness of single versus repeated MSC injections. Outcome measures included WOMAC and VAS scores at 3, 6, and 12 months, as well as the incidence of adverse events (AEs). Traditional meta-analysis and NMA were conducted using Review Manager 5.3 and Stata SE16.0, respectively.

resultsA total of 16 RCTs involving 622 patients were included. Traditional meta-analysis showed that MSC therapy significantly improved pain and knee joint function in KOA patients at different time points (3, 6, and 12 months). The results of the network meta-analysis (NMA) indicated that, compared to single MSC injections, repeated MSC injections provided greater improvements in pain and functional scores at 6 and 12 months, demonstrating superior efficacy. However, repeated MSC injections were also associated with a higher incidence of adverse events.

conclusionsBoth single and repeated MSC injections could improve pain and knee joint function in patients with KOA. Compared to single injections, repeated MSC injections may offer superior therapeutic benefits; however, they are associated with a higher incidence of adverse events. In clinical practice, potential side effects of repeated MSC administration must be carefully considered. Future research should focus on large-scale, multicenter, and long-term randomized controlled trials to further validate the efficacy and safety of MSC therapy for KOA.

Indexed as

Mesenchymal Stem CellsMesenchymal Stem Cell TransplantationOsteoarthritis, KneeHumansRandomized Controlled Trials as TopicTreatment OutcomeEfficacyMesenchymal stem cellsNetwork meta-analysisOsteoarthritisRepeated injections

Identifiers

PMID41013772
PMCPMC12465953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.